MCM6 (Q14566) variants and mutations
MCM6 (also known as Q14566) is a human protein-coding gene encoding a DNA replication licensing factor protein. Within the MCM2-7 helicase, it helps license and unwind DNA for genome duplication. Regulatory variation within the MCM6 locus also controls adult intestinal LCT expression and underlies common lactase-persistence traits. This analysis covers 1,084 MCM6 variants and mutations. Of these, 92% have computational variant effect predictions. Disease context includes lactose intolerance, neurodegenerative disease, and muscle strain. Example MCM6 variants include L3F, L3V, and A4E.
Variant analysis overview
- Gene: MCM6
- Protein: Q14566
- UniProt accession: Q14566
- Organism: Homo sapiens
- Variants analyzed: 1084
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 853 unspecified-consequence records; 1 stop lost; 67 synonymous variants; 134 missense variants; 12 stop-gained variants; 4 splice-region variants; 12 frameshift variants; 1 in-frame insertions
- Prediction scores: 998 variants have prediction scores (92% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: lactose intolerance, neurodegenerative disease, muscle strain, sprain, systemic lupus erythematosus, neurodevelopmental disorder, morbid obesity, hepatocellular carcinoma, breast carcinoma, breast cancer, cancer, gastric cancer.
Protein structure and variant hotspots
- Protein features: 1 domains; 9 binding sites; 9 post-translational modification sites.
- Structural context: 356 variants have structural context.
- PTM context: 11 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable MCM6 variants
Examples include L3F, L3V, A4E, A4G, A4S, A4V, A5E, A5T. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- L3F (p.Leu3Phe), ExAC rs769922920, gnomAD rs769922920, REVEL 0.11, CADD 22.40
- L3V (p.Leu3Val), ExAC rs769922920, gnomAD rs769922920, REVEL 0.09, CADD 18.30
- A4E (p.Ala4Glu), TOPMed rs1680298558, REVEL 0.09, CADD 22.70
- A4G (p.Ala4Gly), TOPMed rs1680298558
- A4S (p.Ala4Ser), TOPMed rs1411055513, gnomAD rs1411055513, REVEL 0.13, CADD 22.50
- A4V (p.Ala4Val), rs1680298558, ClinGen CA348604483, ClinVar RCV004419244, REVEL 0.04, CADD 22.90, Uncertain significance, not specified
- A5E (p.Ala5Glu), TOPMed rs1159523252, gnomAD rs1159523252, REVEL 0.11, CADD 23.00
- A5T (p.Ala5Thr), ESP rs373740116, TOPMed rs373740116, gnomAD rs373740116, REVEL 0.11, CADD 22.50
- A6S (p.Ala6Ser), rs754786359, ClinGen CA1889402, ClinVar RCV004192180, ExAC rs754786359, REVEL 0.03, CADD 18.50, Uncertain significance, not specified
- A6T (p.Ala6Thr), ExAC rs754786359, TOPMed rs754786359, gnomAD rs754786359, REVEL 0.03, CADD 18.80, Uncertain significance
- A7E (p.Ala7Glu), NCI-TCGA TCGA novel, REVEL 0.06, CADD 18.40, Variant assessed as somatic; moderate impact.
- A7G (p.Ala7Gly), ExAC rs750702190, TOPMed rs750702190, gnomAD rs750702190, REVEL 0.06, CADD 20.20, Uncertain significance, not specified
- A7P (p.Ala7Pro), TOPMed rs1680297528
- E8D (p.Glu8Asp), TOPMed rs1680297309, Uncertain significance, not specified
- E8G (p.Glu8Gly), Ensembl rs2105596426
- P9L (p.Pro9Leu), ExAC rs779145315, TOPMed rs779145315, gnomAD rs779145315, REVEL 0.06, CADD 23.70
- P9Q (p.Pro9Gln), ExAC rs779145315, TOPMed rs779145315, gnomAD rs779145315, REVEL 0.08, CADD 22.50
- P9T (p.Pro9Thr), TOPMed rs1414034542, gnomAD rs1414034542, REVEL 0.04, CADD 18.80
- A11T (p.Ala11Thr), ExAC rs753887287, gnomAD rs753887287, REVEL 0.13, CADD 12.60
- A11V (p.Ala11Val), TOPMed rs1680297086, REVEL 0.09, CADD 18.60
- G12A (p.Gly12Ala), ExAC rs200393473, TOPMed rs200393473, gnomAD rs200393473, REVEL 0.12, CADD 23.60
- G12D (p.Gly12Asp), ExAC rs200393473, TOPMed rs200393473, gnomAD rs200393473, REVEL 0.17, CADD 24.20
- G12R (p.Gly12Arg), TOPMed rs891300519, gnomAD rs891300519, REVEL 0.13, CADD 23.90
- G12S (p.Gly12Ser), TOPMed rs891300519, gnomAD rs891300519, REVEL 0.10, CADD 23.90
- S13R (p.Ser13Arg), ExAC rs753172921, TOPMed rs753172921, gnomAD rs753172921
- Q14P (p.Gln14Pro), gnomAD rs1483194687, REVEL 0.17, CADD 22.20
- H15L (p.His15Leu), gnomAD rs1184767359, REVEL 0.34, CADD 16.40
- H15N (p.His15Asn), ExAC rs767901663, gnomAD rs767901663, REVEL 0.06, CADD 20.80
- H15Q (p.His15Gln), TOPMed rs938274968, gnomAD rs938274968, REVEL 0.23, CADD 9.21
- H15Y (p.His15Tyr), ExAC rs767901663, gnomAD rs767901663, REVEL 0.11, CADD 18.00
- E17A (p.Glu17Ala), TOPMed rs1441410836, gnomAD rs1441410836, REVEL 0.09, CADD 22.30
- E17G (p.Glu17Gly), TOPMed rs1441410836, gnomAD rs1441410836, REVEL 0.06, CADD 24.00
- V18I (p.Val18Ile), rs924925153, NCI-TCGA Cosmic COSV5146, TOPMed rs924925153, gnomAD rs924925153, REVEL 0.11, CADD 20.80, Variant assessed as somatic; moderate impact.
- R19H (p.Arg19His), TOPMed rs1029805572, gnomAD rs1029805572, REVEL 0.10, CADD 24.60
- R19L (p.Arg19Leu), TOPMed rs1029805572, gnomAD rs1029805572, REVEL 0.18, CADD 24.10, Uncertain significance, not specified
- D20N (p.Asp20Asn), TOPMed rs1267930393, gnomAD rs1267930393, REVEL 0.45, CADD 28.50
- D20Y (p.Asp20Tyr), NCI-TCGA Cosmic COSV9991, Variant assessed as somatic; moderate impact.
- E21K (p.Glu21Lys), NCI-TCGA Cosmic COSV5147, REVEL 0.28, CADD 23.60, Variant assessed as somatic; moderate impact.
- V22M (p.Val22Met), TOPMed rs1680296277
- K25Q (p.Lys25Gln), TOPMed rs1229479030, gnomAD rs1229479030, REVEL 0.22, CADD 24.00
- Q27R (p.Gln27Arg), TOPMed rs1680296155, gnomAD rs1680296155
- K28N (p.Lys28Asn), ExAC rs773891158, TOPMed rs773891158, gnomAD rs773891158, REVEL 0.12, CADD 22.50
- F30I (p.Phe30Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- F30L (p.Phe30Leu), ExAC rs770552977, TOPMed rs770552977, gnomAD rs770552977, REVEL 0.40, CADD 31.00
- D32V (p.Asp32Val), gnomAD rs1336347501, REVEL 0.16, CADD 24.80
- D32Y (p.Asp32Tyr), gnomAD rs1341194126, REVEL 0.29, CADD 27.60
- E35K (p.Glu35Lys), TOPMed rs1680295695, REVEL 0.21, CADD 23.90
- E35V (p.Glu35Val), rs796879083, UniProt VAR 014816, Ensembl rs796879083, AlphaMissense 0.60, MetaLR 0.08
- E36K (p.Glu36Lys), ExAC rs769402048, TOPMed rs769402048, gnomAD rs769402048, REVEL 0.19, CADD 25.40
- E36Q (p.Glu36Gln), ExAC rs769402048, TOPMed rs769402048, gnomAD rs769402048, REVEL 0.15, CADD 25.00
- Q38E (p.Gln38Glu), gnomAD rs1452704261
- Q38R (p.Gln38Arg), 1000Genomes rs538983384, ExAC rs538983384, gnomAD rs538983384, REVEL 0.07, CADD 19.90
- S39I (p.Ser39Ile), Ensembl rs1009736928, MetaLR 0.01, MetaSVM -0.98
- S39N (p.Ser39Asn), Ensembl rs1009736928, REVEL 0.06, CADD 14.60
- S40R (p.Ser40Arg), 1000Genomes rs150079280, ESP rs150079280, ExAC rs150079280, TOPMed rs150079280, REVEL 0.21, AlphaMissense 0.43
- D41N (p.Asp41Asn), rs376399397, ClinGen CA1889368, ClinVar RCV004262389, ExAC rs376399397, REVEL 0.07, CADD 22.80, Uncertain significance, not specified
- E43K (p.Glu43Lys), NCI-TCGA Cosmic COSV9991, Variant assessed as somatic; moderate impact.
- I44S (p.Ile44Ser), ExAC rs775413016, TOPMed rs775413016, gnomAD rs775413016, MetaLR 0.01, MetaSVM -0.98
- K45T (p.Lys45Thr), TOPMed rs1680226692, MetaLR 0.05, MetaSVM -1.12
- Q48E (p.Gln48Glu), ESP rs141075051, ExAC rs141075051, TOPMed rs141075051, gnomAD rs141075051, REVEL 0.07, CADD 16.90
- Q48K (p.Gln48Lys), ESP rs141075051, ExAC rs141075051, TOPMed rs141075051, gnomAD rs141075051, REVEL 0.05, CADD 21.10
- L49V (p.Leu49Val), ExAC rs777924501, TOPMed rs777924501, gnomAD rs777924501, REVEL 0.03, AlphaMissense 0.89
- A50S (p.Ala50Ser), NCI-TCGA TCGA novel, REVEL 0.35, CADD 23.70, Variant assessed as somatic; moderate impact.
- A50T (p.Ala50Thr), TOPMed rs1455587430, gnomAD rs1455587430, REVEL 0.29, CADD 24.20
- E52V (p.Glu52Val), TOPMed rs1680226213, gnomAD rs1680226213, REVEL 0.32, CADD 25.40
- I54F (p.Ile54Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R55C (p.Arg55Cys), ESP rs139460893, ExAC rs139460893, TOPMed rs139460893, gnomAD rs139460893, REVEL 0.24, CADD 32.00, Uncertain significance
- R55H (p.Arg55His), ExAC rs763275628, TOPMed rs763275628, gnomAD rs763275628, REVEL 0.21, CADD 23.20
- R55S (p.Arg55Ser), rs139460893, ClinGen CA1889361, ClinVar RCV004108475, ESP rs139460893, REVEL 0.21, CADD 23.10, Uncertain significance, not specified
- P56S (p.Pro56Ser), ExAC rs755569944, TOPMed rs755569944, gnomAD rs755569944, REVEL 0.28, CADD 22.80
- R58G (p.Arg58Gly), ExAC rs751992613, gnomAD rs751992613, REVEL 0.31, CADD 25.20
- R58K (p.Arg58Lys), Ensembl rs1680225788, MetaLR 0.07, MetaSVM -1.12
- R58S (p.Arg58Ser), TOPMed rs1165095087, gnomAD rs1165095087, REVEL 0.28, CADD 23.90
- N59K (p.Asn59Lys), Ensembl rs1558764553, REVEL 0.18, CADD 24.60
- T60A (p.Thr60Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L61M (p.Leu61Met), 1000Genomes rs550021704, ExAC rs550021704, TOPMed rs550021704, gnomAD rs550021704, REVEL 0.33, CADD 23.20
- V62I (p.Val62Ile), TOPMed rs1190962067, gnomAD rs1190962067, REVEL 0.11, CADD 18.80
- V62L (p.Val62Leu), NCI-TCGA Cosmic COSV5146, Variant assessed as somatic; moderate impact.
- V63A (p.Val63Ala), ExAC rs758646175, gnomAD rs758646175, REVEL 0.58, CADD 27.40
- V63G (p.Val63Gly), ExAC rs758646175, gnomAD rs758646175, REVEL 0.70, CADD 28.20
- V63L (p.Val63Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V63M (p.Val63Met), rs2467307148, ClinGen CA348603960, ClinVar RCV004105508, Uncertain significance, not specified
- S64G (p.Ser64Gly), Ensembl rs970315370, MetaLR 0.05, MetaSVM -1.14
- V66M (p.Val66Met), rs1558764542, NCI-TCGA Cosmic COSV5146, Ensembl rs1558764542, REVEL 0.02, CADD 15.00, Variant assessed as somatic; moderate impact.
- D67E (p.Asp67Glu), ExAC rs750109785, TOPMed rs750109785, gnomAD rs750109785, REVEL 0.13, CADD 19.50
- E69G (p.Glu69Gly), ESP rs373573044, ExAC rs373573044, TOPMed rs373573044, gnomAD rs373573044, REVEL 0.39, CADD 23.50
- Q70P (p.Gln70Pro), TOPMed rs1477058297, gnomAD rs1477058297, REVEL 0.18, CADD 22.60
- F71L (p.Phe71Leu), ExAC rs776345642, TOPMed rs776345642, gnomAD rs776345642, REVEL 0.20, CADD 23.00, Uncertain significance, not specified
- N72K (p.Asn72Lys), TOPMed rs1369380418, gnomAD rs1369380418, REVEL 0.17, CADD 23.20
- N72S (p.Asn72Ser), TOPMed rs1680224928, REVEL 0.12, CADD 22.20
- Q73* (p.Gln73Ter), Ensembl rs1558764534
- S76A (p.Ser76Ala), Ensembl rs1680224758
- S76F (p.Ser76Phe), gnomAD rs201423668, REVEL 0.35, CADD 27.90
- I79V (p.Ile79Val), 1000Genomes rs567110296, ExAC rs567110296, gnomAD rs567110296, REVEL 0.11, CADD 18.50, Uncertain significance, not specified
- E81G (p.Glu81Gly), TOPMed rs752176648, gnomAD rs752176648, REVEL 0.33, CADD 31.00
- E81K (p.Glu81Lys), NCI-TCGA TCGA novel, REVEL 0.24, CADD 25.00, Variant assessed as somatic; moderate impact.
- E81V (p.Glu81Val), TOPMed rs752176648, gnomAD rs752176648, REVEL 0.37, CADD 28.90
- E82K (p.Glu82Lys), NCI-TCGA Cosmic COSV9991, Variant assessed as somatic; moderate impact.
- F83L (p.Phe83Leu), NCI-TCGA Cosmic COSV5146, MetaLR 0.05, MetaSVM -1.14, Variant assessed as somatic; moderate impact.
- Y84C (p.Tyr84Cys), ExAC rs771924466, TOPMed rs771924466, gnomAD rs771924466, REVEL 0.57, CADD 32.00
- Y84H (p.Tyr84His), rs775251514, ClinGen CA1889349, ClinVar RCV004288508, ExAC rs775251514, REVEL 0.52, CADD 28.50, Uncertain significance, not specified
- Y84S (p.Tyr84Ser), ExAC rs771924466, TOPMed rs771924466, gnomAD rs771924466, REVEL 0.60, CADD 28.80
- R85K (p.Arg85Lys), NCI-TCGA Cosmic COSV9991, Variant assessed as somatic; moderate impact.
- R85S (p.Arg85Ser), ExAC rs776797839, gnomAD rs776797839, REVEL 0.45, CADD 26.00
- R85T (p.Arg85Thr), Ensembl rs1680223887, MetaLR 0.18, MetaSVM -0.59
- V86I (p.Val86Ile), NCI-TCGA TCGA novel, SIFT 0.27, Variant assessed as somatic; moderate impact.
- Y87C (p.Tyr87Cys), gnomAD rs1255593627, REVEL 0.61, CADD 28.90
- P88L (p.Pro88Leu), Ensembl rs1680177521, MetaLR 0.16, MetaSVM -0.62
- Y89* (p.Tyr89Ter), gnomAD rs1462836086, CADD 33.00
- C91R (p.Cys91Arg), ExAC rs756125742, TOPMed rs756125742, gnomAD rs756125742, REVEL 0.45, CADD 23.90
- R92Q (p.Arg92Gln), rs61750436, ClinGen CA1889320, ClinVar RCV003954725, ClinVar RCV005426287, REVEL 0.15, CADD 22.60, Likely benign, not provided
- R92W (p.Arg92Trp), rs61752701, ClinGen CA1889321, ClinVar RCV003911728, 1000Genomes rs61752701, REVEL 0.37, CADD 32.00, Likely benign, MCM6-related disorder
- A93S (p.Ala93Ser), ExAC rs746364726, TOPMed rs746364726, gnomAD rs746364726, REVEL 0.18, CADD 24.70, Uncertain significance, not specified
- T96I (p.Thr96Ile), TOPMed rs1680177033, REVEL 0.04, CADD 22.50
- F97I (p.Phe97Ile), ExAC rs779470520, gnomAD rs779470520, MetaLR 0.02, MetaSVM -0.90
- F97L (p.Phe97Leu), rs779470520, NCI-TCGA Cosmic COSV5146, ExAC rs779470520, gnomAD rs779470520, REVEL 0.27, CADD 13.70, Variant assessed as somatic; moderate impact.
- F97Y (p.Phe97Tyr), rs376597944, ClinGen CA1889317, ClinVar RCV004419251, ESP rs376597944, REVEL 0.17, CADD 22.70, Uncertain significance, not specified
- V98I (p.Val98Ile), ESP rs375834809, ExAC rs375834809, TOPMed rs375834809, gnomAD rs375834809, REVEL 0.07, CADD 20.80
- V98L (p.Val98Leu), ESP rs375834809, ExAC rs375834809, TOPMed rs375834809, gnomAD rs375834809, REVEL 0.09, CADD 22.40
- K99E (p.Lys99Glu), TOPMed rs1680176856, REVEL 0.14, CADD 22.20
- K99R (p.Lys99Arg), TOPMed rs1575368349, gnomAD rs1575368349, REVEL 0.11, CADD 18.80
- R101C (p.Arg101Cys), rs767037709, NCI-TCGA Cosmic COSV5146, ExAC rs767037709, TOPMed rs767037709, REVEL 0.20, CADD 25.10, Variant assessed as somatic; moderate impact.
- R101G (p.Arg101Gly), ExAC rs767037709, TOPMed rs767037709, gnomAD rs767037709, REVEL 0.14, CADD 22.80
- R101H (p.Arg101His), 1000Genomes rs566522057, ExAC rs566522057, TOPMed rs566522057, gnomAD rs566522057, REVEL 0.07, CADD 21.20
- R101L (p.Arg101Leu), 1000Genomes rs566522057, ExAC rs566522057, TOPMed rs566522057, gnomAD rs566522057, REVEL 0.11, CADD 22.00
- K102R (p.Lys102Arg), TOPMed rs1434786345, gnomAD rs1434786345, REVEL 0.08, CADD 22.10
- I104F (p.Ile104Phe), ExAC rs766197896, TOPMed rs766197896, gnomAD rs766197896, REVEL 0.13, CADD 22.20
- I104T (p.Ile104Thr), Ensembl rs1342195996, MetaLR 0.03, MetaSVM -1.05
- I104V (p.Ile104Val), ExAC rs766197896, TOPMed rs766197896, gnomAD rs766197896, REVEL 0.11, CADD 17.70
- P105L (p.Pro105Leu), rs1291101798, ClinGen CA348603402, ClinVar RCV004121477, gnomAD rs1291101798, REVEL 0.30, CADD 23.20, Uncertain significance, not specified
- A107T (p.Ala107Thr), ExAC rs762691120, TOPMed rs762691120, gnomAD rs762691120, REVEL 0.04, CADD 20.60
- K108N (p.Lys108Asn), 1000Genomes rs553009731, ExAC rs553009731, gnomAD rs553009731, NCI-TCGA TCGA novel, REVEL 0.27, CADD 25.00, Variant assessed as somatic; moderate impact.
- K108R (p.Lys108Arg), TOPMed rs1431157013, REVEL 0.17, CADD 23.00
- D109A (p.Asp109Ala), NCI-TCGA Cosmic COSV5146, MetaLR 0.03, MetaSVM -1.08, Variant assessed as somatic; moderate impact.
- D109E (p.Asp109Glu), ExAC rs760949511, gnomAD rs760949511, REVEL 0.13, CADD 13.40
- D109V (p.Asp109Val), gnomAD rs1680176201, REVEL 0.27, CADD 24.00
- A113T (p.Ala113Thr), ESP rs149573817, ExAC rs149573817, TOPMed rs149573817, gnomAD rs149573817, REVEL 0.20, CADD 24.00
- A113V (p.Ala113Val), rs772169779, ClinGen CA1889303, ClinVar RCV004115406, ExAC rs772169779, REVEL 0.42, CADD 28.20, Uncertain significance, not specified
- Q115* (p.Gln115Ter), Ensembl rs1680175955
- Q115R (p.Gln115Arg), gnomAD rs1680175930, REVEL 0.08, CADD 22.20
- D116A (p.Asp116Ala), Ensembl rs1575368299, MetaLR 0.06, MetaSVM -1.11
- D116N (p.Asp116Asn), gnomAD rs1262210598, REVEL 0.17, CADD 22.90
- P118L (p.Pro118Leu), ExAC rs774949484, gnomAD rs774949484, REVEL 0.32, CADD 25.30
- K122R (p.Lys122Arg), TOPMed rs1680175653, REVEL 0.07, CADD 22.30
- I123M (p.Ile123Met), gnomAD rs1407333908, REVEL 0.17, CADD 22.90
- I123S (p.Ile123Ser), Ensembl rs201187605, MetaLR 0.11, MetaSVM -0.82
- I123V (p.Ile123Val), ExAC rs767727857, gnomAD rs767727857, REVEL 0.21, CADD 21.20
- R124* (p.Arg124Ter), rs1348642360, NCI-TCGA Cosmic COSV5146, gnomAD rs1348642360, CADD 37.00, Variant assessed as somatic; high impact.
- R124Q (p.Arg124Gln), ExAC rs759630219, gnomAD rs759630219, REVEL 0.69, CADD 28.20
- L126H (p.Leu126His), ExAC rs775002412, gnomAD rs775002412, REVEL 0.73, CADD 28.50
- T127I (p.Thr127Ile), TOPMed rs1398903284, gnomAD rs1398903284, REVEL 0.28, CADD 23.50
- S129T (p.Ser129Thr), ExAC rs749796617, TOPMed rs749796617, gnomAD rs749796617, REVEL 0.04, CADD 20.40, Uncertain significance, not specified
- S129Y (p.Ser129Tyr), TOPMed rs1680147792, gnomAD rs1680147792, REVEL 0.13, CADD 23.90
- R130G (p.Arg130Gly), ExAC rs773494816, TOPMed rs773494816, gnomAD rs773494816, REVEL 0.17, CADD 23.90, Uncertain significance, not specified
- R130K (p.Arg130Lys), ExAC rs770160411, gnomAD rs770160411, REVEL 0.09, CADD 17.80
- G132D (p.Gly132Asp), Ensembl rs1680147497, REVEL 0.53, CADD 26.00
- L133F (p.Leu133Phe), gnomAD rs1249601475, REVEL 0.05, CADD 17.90
- L134F (p.Leu134Phe), ExAC rs780852550, gnomAD rs780852550, REVEL 0.40, CADD 25.90
- T135S (p.Thr135Ser), ExAC rs754500820, REVEL 0.10, CADD 22.00
- R136C (p.Arg136Cys), rs189085457, ClinGen CA1889276, ClinVar RCV004181247, 1000Genomes rs189085457, REVEL 0.10, CADD 23.50, Uncertain significance, not specified
- R136H (p.Arg136His), rs201215953, ClinGen CA1889275, ClinVar RCV003932137, 1000Genomes rs201215953, REVEL 0.25, CADD 25.80, Likely benign, MCM6-related disorder
- R136L (p.Arg136Leu), 1000Genomes rs201215953, ESP rs201215953, ExAC rs201215953, TOPMed rs201215953, REVEL 0.16, CADD 22.80, Likely benign
- I137L (p.Ile137Leu), TOPMed rs1002471707, gnomAD rs1002471707, REVEL 0.26, CADD 26.60
- I137V (p.Ile137Val), TOPMed rs1002471707, gnomAD rs1002471707, REVEL 0.18, CADD 24.80
- V141L (p.Val141Leu), NCI-TCGA Cosmic COSV5146, Variant assessed as somatic; moderate impact.
- R143Q (p.Arg143Gln), TOPMed rs924347913, gnomAD rs924347913, REVEL 0.48, CADD 27.50, Uncertain significance, not specified
- R143W (p.Arg143Trp), rs750353136, NCI-TCGA Cosmic COSV5146, ExAC rs750353136, TOPMed rs750353136, REVEL 0.47, CADD 32.00, Variant assessed as somatic; moderate impact.
- T144I (p.Thr144Ile), ExAC rs764982636, TOPMed rs764982636, gnomAD rs764982636, REVEL 0.43, CADD 26.00
- P146A (p.Pro146Ala), TOPMed rs1209449415, gnomAD rs1209449415
- P146L (p.Pro146Leu), TOPMed rs1680146131
- P146T (p.Pro146Thr), TOPMed rs1209449415, gnomAD rs1209449415
- V147A (p.Val147Ala), NCI-TCGA TCGA novel, MetaLR 0.10, MetaSVM -0.80, Variant assessed as somatic; moderate impact.
- V147F (p.Val147Phe), ExAC rs754390262, TOPMed rs754390262, gnomAD rs754390262, REVEL 0.37, CADD 25.90
- V147I (p.Val147Ile), ExAC rs754390262, TOPMed rs754390262, gnomAD rs754390262, REVEL 0.18, CADD 23.30
- H148Y (p.His148Tyr), TOPMed rs1276470233, gnomAD rs1276470233, REVEL 0.40, CADD 26.60
- P149S (p.Pro149Ser), rs774059991, UniProt VAR 088369, Ensembl rs774059991, AlphaMissense 0.99, MetaLR 0.13, Uncertain significance
- E150G (p.Glu150Gly), Ensembl rs1575367591, REVEL 0.63, CADD 29.80
- V152L (p.Val152Leu), TOPMed rs1680145737
- S153G (p.Ser153Gly), Ensembl rs1680145673, MetaLR 0.01, MetaSVM -0.92
- G154R (p.Gly154Arg), ExAC rs767781045, TOPMed rs767781045, gnomAD rs767781045, REVEL 0.62, CADD 27.80
Public MCM6 analysis runs
- MCM6 analysis run — MCM6 (1,084 variants) — completed 2026-08-20